BioStem Technologies to Present at TD Cowen Healthcare Conference

BioStem Technologies, Inc., a MedTech company specializing in perinatal tissue-derived products for advanced wound care, announced that company management will present at the 46th Annual TD Cowen Healthcare Conference in Boston, Massachusetts. The presentation is scheduled for Monday, March 2, 2026, at 3:50 pm ET. This conference appearance provides BioStem with a platform to engage with investors and industry stakeholders about its innovative regenerative medicine solutions.

The company focuses on developing, manufacturing, and commercializing allografts using its proprietary BioRetain® processing method, which aims to maintain growth factors and preserve tissue structure. BioStem's quality management system and standard operating procedures have been accredited by the American Association of Tissue Banks and comply with current Good Tissue Practices and current Good Manufacturing Processes. Its product portfolio includes brands such as VENDAJE®, VENDAJE AC®, American Amnion™, American Amnion AC™, Neox®, and Clarix®.

Interested parties can access live and archived webcasts of the presentation through the investors section of the company's website at https://ir.biostemtechnologies.com. This event represents an opportunity for BioStem to showcase its advancements in regenerative therapies and discuss its strategic direction in the competitive healthcare market. The presentation at a major industry conference underscores the company's commitment to transparency and investor communication as it continues to develop products aimed at improving patient outcomes in wound care.

For additional information about BioStem Technologies, visit https://biostemtechnologies.com. The company's participation in the TD Cowen Healthcare Conference highlights the growing importance of regenerative medicine in addressing complex medical needs and positions BioStem as a key player in this evolving field. This presentation allows the company to demonstrate how its technology and products contribute to advancing medical treatments and potentially expanding its market presence.